SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Helius Medical Technologies, Inc. – ‘10-K’ for 12/31/22 – ‘EX-101.PRE’

On:  Thursday, 3/9/23, at 4:39pm ET   ·   For:  12/31/22   ·   Accession #:  1558370-23-3338   ·   File #:  1-38445

Previous ‘10-K’:  ‘10-K’ on 3/14/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 3/28/24 for 12/31/23   ·   30 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/09/23  Helius Medical Technologies, Inc. 10-K       12/31/22   76:7.8M                                   Toppan Merrill Bridge/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.87M 
 2: EX-21.1     Subsidiaries List                                   HTML     22K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     21K 
 4: EX-23.2     Consent of Expert or Counsel                        HTML     21K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
13: R1          Document and Entity Information                     HTML     92K 
14: R2          Consolidated Balance Sheets                         HTML    123K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     38K 
16: R4          Consolidated Statements of Operations and           HTML    133K 
                Comprehensive Loss                                               
17: R5          Consolidated Statements of Stockholders' Equity     HTML     91K 
18: R6          Consolidated Statements of Cash Flows               HTML    123K 
19: R7          Description of Business                             HTML     27K 
20: R8          Significant Accounting Policies                     HTML     40K 
21: R9          Goodwill Impairment                                 HTML     24K 
22: R10         Supplemental Balance Sheet Disclosures              HTML     83K 
23: R11         Leases                                              HTML     35K 
24: R12         Intangible Assets                                   HTML     70K 
25: R13         Fair Value Measurements                             HTML     27K 
26: R14         Common Stock and Warrants                           HTML     64K 
27: R15         Stock-Based Compensation                            HTML    102K 
28: R16         Basic and Diluted Loss Per Share                    HTML     55K 
29: R17         Income Taxes                                        HTML    122K 
30: R18         Defined Contribution Plan                           HTML     24K 
31: R19         Commitments and Contingencies                       HTML     24K 
32: R20         Enterprise-Wide Disclosures                         HTML     42K 
33: R21         Significant Accounting Policies (Policies)          HTML     96K 
34: R22         Supplemental Balance Sheet Disclosures (Tables)     HTML     85K 
35: R23         Leases (Tables)                                     HTML     34K 
36: R24         Intangible Assets (Tables)                          HTML     72K 
37: R25         Common Stock and Warrants (Tables)                  HTML     53K 
38: R26         Stock-Based Compensation (Tables)                   HTML    101K 
39: R27         Basic and Diluted Loss Per Share (Tables)           HTML     56K 
40: R28         Income Taxes (Tables)                               HTML    125K 
41: R29         Enterprise-Wide Disclosures (Tables)                HTML     37K 
42: R30         Description of Business (Details)                   HTML     36K 
43: R31         SIGNIFICANT ACCOUNTING POLICIES - Additional        HTML     34K 
                Information (Details)                                            
44: R32         Goodwill Impairment (Details)                       HTML     26K 
45: R33         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Accounts   HTML     30K 
                receivable, net (Details)                                        
46: R34         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Inventory  HTML     35K 
                (Details)                                                        
47: R35         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Prepaid    HTML     27K 
                expenses and other current assets (Details)                      
48: R36         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Property   HTML     35K 
                and equipment, net (Details)                                     
49: R37         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Accrued    HTML     36K 
                Expenses (Details)                                               
50: R38         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Deferred   HTML     47K 
                Revenue (Details)                                                
51: R39         Leases (Details)                                    HTML     48K 
52: R40         INTANGIBLE ASSETS - Summary (Details)               HTML     39K 
53: R41         INTANGIBLE ASSETS - Estimated Amortization Expense  HTML     28K 
                (Details)                                                        
54: R42         COMMON STOCK AND WARRANTS - Additional Information  HTML    107K 
                (Details)                                                        
55: R43         COMMON STOCK AND WARRANTS - Summary of Weighted     HTML     70K 
                Average Assumptions Used in Estimating Fair Value                
                of Warrants (Details)                                            
56: R44         COMMON STOCK AND WARRANTS - Summary of Warrant      HTML     39K 
                Activity (Details)                                               
57: R45         STOCK-BASED COMPENSATION - Additional Information-  HTML     67K 
                (Details)                                                        
58: R46         STOCK-BASED COMPENSATION - Fair Value Assumptions   HTML     33K 
                (Details)                                                        
59: R47         STOCK-BASED COMPENSATION - Summary of Company's     HTML     48K 
                Stock Option Activity (Details)                                  
60: R48         STOCK-BASED COMPENSATION - Other Awards (Details)   HTML     38K 
61: R49         STOCK-BASED COMPENSATION - Stock-Based              HTML     30K 
                Compensation Expense (Details)                                   
62: R50         Basic and Diluted Loss Per Share (Details)          HTML     50K 
63: R51         Basic and Diluted Loss Per Share - Antidilutive     HTML     30K 
                Securities (Details)                                             
64: R52         INCOME TAXES - Components of Net Loss for Income    HTML     31K 
                Tax (Details)                                                    
65: R53         INCOME TAXES - Reconciliation of Income Tax         HTML     47K 
                Provision Computed at Statutory Rates (Details)                  
66: R54         INCOME TAXES - Components of Deferred Income Tax    HTML     60K 
                Assets and Liabilities (Details)                                 
67: R55         INCOME TAXES - Net operating losses (Details)       HTML     46K 
68: R56         INCOME TAXES - Tax credit carryforward (Details)    HTML     37K 
69: R57         Defined Contribution Plan (Details)                 HTML     30K 
70: R58         COMMITMENTS AND CONTINGENCIES - Additional          HTML     27K 
                Information (Details)                                            
71: R59         Enterprise-Wide Disclosures (Details)               HTML     52K 
74: XML         IDEA XML File -- Filing Summary                      XML    135K 
72: XML         XBRL Instance -- hsdt-20221231x10k_htm               XML   1.59M 
73: EXCEL       IDEA Workbook of Financial Reports                  XLSX    124K 
 9: EX-101.CAL  XBRL Calculations -- hsdt-20221231_cal               XML    190K 
10: EX-101.DEF  XBRL Definitions -- hsdt-20221231_def                XML    474K 
11: EX-101.LAB  XBRL Labels -- hsdt-20221231_lab                     XML   1.36M 
12: EX-101.PRE  XBRL Presentations -- hsdt-20221231_pre              XML    930K 
 8: EX-101.SCH  XBRL Schema -- hsdt-20221231                         XSD    160K 
75: JSON        XBRL Instance as JSON Data -- MetaLinks              423±   675K 
76: ZIP         XBRL Zipped Folder -- 0001558370-23-003338-xbrl      Zip    448K

‘EX-101.PRE’   —   XBRL Presentations — hsdt-20221231_pre

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL document created with Toppan Merrill Bridge 10.2.0.4 -->
<!-- Based on XBRL 2.1 -->
<!-- Created on: 3/9/2023 8:49:19 PM -->
<!-- Modified on: 3/9/2023 8:49:19 PM -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/StatementConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#StatementConsolidatedBalanceSheetsParenthetical" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#StatementConsolidatedStatementsOfStockholdersEquity" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureDescriptionOfBusiness" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureDescriptionOfBusiness" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSignificantAccountingPolicies" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureSignificantAccountingPolicies" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureGoodwillImpairment" roleURI="http://www.heliusmedical.com/role/DisclosureGoodwillImpairment" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSupplementalBalanceSheetDisclosures" roleURI="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosures" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureLeases" roleURI="http://www.heliusmedical.com/role/DisclosureLeases" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIntangibleAssets" roleURI="http://www.heliusmedical.com/role/DisclosureIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureFairValueMeasurements" roleURI="http://www.heliusmedical.com/role/DisclosureFairValueMeasurements" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureCommonStockAndWarrants" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureCommonStockAndWarrants" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureStockBasedCompensation" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureBasicAndDilutedLossPerShare" roleURI="http://www.heliusmedical.com/role/DisclosureBasicAndDilutedLossPerShare" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIncomeTaxes" roleURI="http://www.heliusmedical.com/role/DisclosureIncomeTaxes" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureDefinedContributionPlan" roleURI="http://www.heliusmedical.com/role/DisclosureDefinedContributionPlan" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureCommitmentsAndContingencies" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureCommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureEnterpriseWideDisclosures" roleURI="http://www.heliusmedical.com/role/DisclosureEnterpriseWideDisclosures" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSignificantAccountingPoliciesPolicies" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSupplementalBalanceSheetDisclosuresTables" roleURI="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresTables" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureLeasesTables" roleURI="http://www.heliusmedical.com/role/DisclosureLeasesTables" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIntangibleAssetsTables" roleURI="http://www.heliusmedical.com/role/DisclosureIntangibleAssetsTables" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureCommonStockAndWarrantsTables" roleURI="http://www.heliusmedical.com/role/DisclosureCommonStockAndWarrantsTables" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureStockBasedCompensationTables" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensationTables" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureBasicAndDilutedLossPerShareTables" roleURI="http://www.heliusmedical.com/role/DisclosureBasicAndDilutedLossPerShareTables" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIncomeTaxesTables" roleURI="http://www.heliusmedical.com/role/DisclosureIncomeTaxesTables" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureEnterpriseWideDisclosuresTables" roleURI="http://www.heliusmedical.com/role/DisclosureEnterpriseWideDisclosuresTables" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureDescriptionOfBusinessDetails" roleURI="http://www.heliusmedical.com/role/DisclosureDescriptionOfBusinessDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureGoodwillImpairmentDetails" roleURI="http://www.heliusmedical.com/role/DisclosureGoodwillImpairmentDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSupplementalBalanceSheetDisclosuresAccountsReceivableNetDetails" roleURI="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresAccountsReceivableNetDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSupplementalBalanceSheetDisclosuresInventoryDetails" roleURI="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresInventoryDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSupplementalBalanceSheetDisclosuresPrepaidExpensesAndOtherCurrentAssetsDetails" roleURI="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresPrepaidExpensesAndOtherCurrentAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSupplementalBalanceSheetDisclosuresPropertyAndEquipmentNetDetails" roleURI="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresPropertyAndEquipmentNetDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSupplementalBalanceSheetDisclosuresAccruedExpensesDetails" roleURI="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresAccruedExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureSupplementalBalanceSheetDisclosuresDeferredRevenueDetails" roleURI="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresDeferredRevenueDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureLeasesDetails" roleURI="http://www.heliusmedical.com/role/DisclosureLeasesDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIntangibleAssetsSummaryDetails" roleURI="http://www.heliusmedical.com/role/DisclosureIntangibleAssetsSummaryDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIntangibleAssetsEstimatedAmortizationExpenseDetails" roleURI="http://www.heliusmedical.com/role/DisclosureIntangibleAssetsEstimatedAmortizationExpenseDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureCommonStockAndWarrantsAdditionalInformationDetails" roleURI="http://www.heliusmedical.com/role/DisclosureCommonStockAndWarrantsAdditionalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureCommonStockAndWarrantsSummaryOfWeightedAverageAssumptionsUsedInEstimatingFairValueOfWarrantsDetails" roleURI="http://www.heliusmedical.com/role/DisclosureCommonStockAndWarrantsSummaryOfWeightedAverageAssumptionsUsedInEstimatingFairValueOfWarrantsDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureCommonStockAndWarrantsSummaryOfWarrantActivityDetails" roleURI="http://www.heliusmedical.com/role/DisclosureCommonStockAndWarrantsSummaryOfWarrantActivityDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureStockBasedCompensationAdditionalInformationDetails" roleURI="http://www.heliusmedical.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureStockBasedCompensationFairValueAssumptionsDetails" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensationFairValueAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureStockBasedCompensationSummaryOfCompanySStockOptionActivityDetails" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCompanySStockOptionActivityDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureStockBasedCompensationOtherAwardsDetails" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensationOtherAwardsDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureBasicAndDilutedLossPerShareDetails" roleURI="http://www.heliusmedical.com/role/DisclosureBasicAndDilutedLossPerShareDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureBasicAndDilutedLossPerShareAntidilutiveSecuritiesDetails" roleURI="http://www.heliusmedical.com/role/DisclosureBasicAndDilutedLossPerShareAntidilutiveSecuritiesDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIncomeTaxesComponentsOfNetLossForIncomeTaxDetails" roleURI="http://www.heliusmedical.com/role/DisclosureIncomeTaxesComponentsOfNetLossForIncomeTaxDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIncomeTaxesReconciliationOfIncomeTaxProvisionComputedAtStatutoryRatesDetails" roleURI="http://www.heliusmedical.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxProvisionComputedAtStatutoryRatesDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIncomeTaxesComponentsOfDeferredIncomeTaxAssetsAndLiabilitiesDetails" roleURI="http://www.heliusmedical.com/role/DisclosureIncomeTaxesComponentsOfDeferredIncomeTaxAssetsAndLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIncomeTaxesNetOperatingLossesDetails" roleURI="http://www.heliusmedical.com/role/DisclosureIncomeTaxesNetOperatingLossesDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureIncomeTaxesTaxCreditCarryforwardDetails" roleURI="http://www.heliusmedical.com/role/DisclosureIncomeTaxesTaxCreditCarryforwardDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureDefinedContributionPlanDetails" roleURI="http://www.heliusmedical.com/role/DisclosureDefinedContributionPlanDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" roleURI="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<roleRef xlink:type="simple" xlink:href="hsdt-20221231.xsd#DisclosureEnterpriseWideDisclosuresDetails" roleURI="http://www.heliusmedical.com/role/DisclosureEnterpriseWideDisclosuresDetails" xmlns="http://www.xbrl.org/2003/linkbase"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638139917570973540"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638139917570973540" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport_638139917570973540"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentAnnualReport_638139917570973540" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_638139917570973540"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentTransitionReport_638139917570973540" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer_638139917570973540"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer_638139917570973540" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers_638139917570973540"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityVoluntaryFilers_638139917570973540" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638139917570973540"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638139917570973540" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638139917570973540"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638139917570973540" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_638139917570973540"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus_638139917570973540" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_638139917570983598"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus_638139917570983598" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638139917570983598"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638139917570983598" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638139917570983598"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638139917570983598" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638139917570983598"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638139917570983598" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_638139917570983598"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate_638139917570983598" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_638139917570983598"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFilerCategory_638139917570983598" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness_638139917570983598"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntitySmallBusiness_638139917570983598" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638139917570983598"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638139917570983598" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_638139917570983598"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding_638139917570983598" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_638139917570993491"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus_638139917570993491" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_638139917570993491"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityShellCompany_638139917570993491" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638139917570993491"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638139917570993491" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638139917570993491"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638139917570993491" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638139917570993491"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638139917570993491" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638139917570993491"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638139917570993491" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638139917570993491"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638139917570993491" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638139917570993491"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638139917570993491" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638139917570993491"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638139917570993491" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638139917571003471"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638139917571003471" order="27" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638139917571003471"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638139917571003471" order="28" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638139917571003471"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638139917571003471" order="29" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638139917571003471"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638139917571003471" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_638139917571003471"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent_638139917571003471" order="31" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag_638139917571003471"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag_638139917571003471" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat_638139917571003471"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityPublicFloat_638139917571003471" order="33" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId_638139917571013486"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AuditorFirmId_638139917571013486" order="34" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName_638139917571013486"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AuditorName_638139917571013486" order="35" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation_638139917571013486"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AuditorLocation_638139917571013486" order="36" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_638139917571013486"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_638139917571013486" order="37" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Consolidated Balance Sheets" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_638139917571013486"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract_638139917571013486" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638139917571013486" xlink:to="us-gaap_AssetsCurrentAbstract_638139917571023630" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638139917571023630" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638139917571023630" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638139917571023630" xlink:to="us-gaap_AccountsReceivableNetCurrent_638139917571023630" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638139917571023630" xlink:to="us-gaap_OtherReceivablesNetCurrent_638139917571023630" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638139917571023630" xlink:to="us-gaap_InventoryNet_638139917571023630" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638139917571023630" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_638139917571023630" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638139917571023630" xlink:to="us-gaap_AssetsCurrent_638139917571023630" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638139917571013486" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_638139917571023630" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638139917571013486" xlink:to="us-gaap_Goodwill_638139917571023630" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638139917571013486" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_638139917571023630" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_638139917571023630"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638139917571013486" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_638139917571023630" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_638139917571033469"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638139917571013486" xlink:to="us-gaap_Assets_638139917571033469" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638139917571033469"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638139917571033469" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_638139917571033469"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638139917571033469" xlink:to="us-gaap_LiabilitiesCurrentAbstract_638139917571033469" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_638139917571033469"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638139917571033469" xlink:to="us-gaap_AccountsPayableCurrent_638139917571033469" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_AccruedAndOtherCurrentLiabilities." xlink:label="hsdt_AccruedAndOtherCurrentLiabilities._638139917571033469"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638139917571033469" xlink:to="hsdt_AccruedAndOtherCurrentLiabilities._638139917571033469" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_638139917571033469"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638139917571033469" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_638139917571033469" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_638139917571033469"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638139917571033469" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_638139917571033469" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638139917571033469"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638139917571033469" xlink:to="us-gaap_LiabilitiesCurrent_638139917571033469" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_638139917571033469"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638139917571033469" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_638139917571033469" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_638139917571043517"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638139917571033469" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_638139917571043517" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_638139917571043517"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638139917571033469" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_638139917571043517" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_638139917571043517"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638139917571033469" xlink:to="us-gaap_Liabilities_638139917571043517" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_638139917571043517"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638139917571033469" xlink:to="us-gaap_CommitmentsAndContingencies_638139917571043517" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_638139917571043517"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638139917571033469" xlink:to="us-gaap_StockholdersEquityAbstract_638139917571043517" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_638139917571043517"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638139917571043517" xlink:to="us-gaap_PreferredStockValue_638139917571043517" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638139917571043517"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638139917571043517" xlink:to="us-gaap_CommonStockValue_638139917571043517" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_638139917571053524"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638139917571043517" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_638139917571053524" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638139917571053524"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638139917571043517" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638139917571053524" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_638139917571053524"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638139917571043517" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_638139917571053524" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638139917571053524"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638139917571043517" xlink:to="us-gaap_StockholdersEquity_638139917571053524" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_638139917571053524"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638139917571033469" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_638139917571053524" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:type="extended" xlink:title="00105 - Statement - Consolidated Balance Sheets (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_638139917571063265"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_638139917571063265" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_638139917571063265"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized_638139917571063265" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_638139917571063265"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued_638139917571063265" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_638139917571063265"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding_638139917571063265" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638139917571063265"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638139917571063265" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_638139917571063265"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized_638139917571063265" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_638139917571063265"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued_638139917571063265" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638139917571063265"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding_638139917571063265" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="extended" xlink:title="00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="StatementOfIncomeAndComprehensiveIncomeAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract_638139917571073518"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_RevenuesAbstract_638139917571073518" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638139917571073518"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract_638139917571073518" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638139917571073518" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_638139917571073518"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract_638139917571073518" xlink:to="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_638139917571073518" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueNotFromContractWithCustomerOther" xlink:label="us-gaap_RevenueNotFromContractWithCustomerOther_638139917571073518"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract_638139917571073518" xlink:to="us-gaap_RevenueNotFromContractWithCustomerOther_638139917571073518" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_638139917571073518"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract_638139917571073518" xlink:to="us-gaap_Revenues_638139917571073518" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAbstract_638139917571093441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSoldAbstract_638139917571093441" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold_638139917571093441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfGoodsAndServicesSoldAbstract_638139917571093441" xlink:to="us-gaap_CostOfGoodsAndServicesSold_638139917571093441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:label="us-gaap_TypeOfCostGoodOrServiceExtensibleList_638139917571093441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfGoodsAndServicesSoldAbstract_638139917571093441" xlink:to="us-gaap_TypeOfCostGoodOrServiceExtensibleList_638139917571093441" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit_638139917571093441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_GrossProfit_638139917571093441" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract_638139917571093441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_638139917571093441" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_638139917571093441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638139917571093441" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_638139917571093441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_638139917571093441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638139917571093441" xlink:to="us-gaap_ResearchAndDevelopmentExpense_638139917571093441" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_638139917571093441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638139917571093441" xlink:to="us-gaap_AmortizationOfIntangibleAssets_638139917571093441" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss_638139917571093441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638139917571093441" xlink:to="us-gaap_GoodwillImpairmentLoss_638139917571093441" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_638139917571103682"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638139917571093441" xlink:to="us-gaap_OperatingExpenses_638139917571103682" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638139917571103682"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OperatingIncomeLoss_638139917571103682" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_638139917571103682"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_638139917571103682" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_638139917571103682"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638139917571103682" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet_638139917571103682" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_638139917571103682"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638139917571103682" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_638139917571103682" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ForeignCurrencyTransactionIncludingOtherGainLossBeforeTax" xlink:label="hsdt_ForeignCurrencyTransactionIncludingOtherGainLossBeforeTax_638139917571103682"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638139917571103682" xlink:to="hsdt_ForeignCurrencyTransactionIncludingOtherGainLossBeforeTax_638139917571103682" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome_638139917571103682"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638139917571103682" xlink:to="us-gaap_OtherNonoperatingIncome_638139917571103682" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_638139917571103682"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638139917571103682" xlink:to="us-gaap_NonoperatingIncomeExpense_638139917571103682" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638139917571103682"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638139917571103682" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638139917571113443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638139917571113443" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638139917571113443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss_638139917571113443" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_638139917571113443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_638139917571113443" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_638139917571113443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_638139917571113443" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_638139917571113443" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_638139917571113443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_638139917571113443" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract_638139917571113443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_EarningsPerShareReconciliationAbstract_638139917571113443" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638139917571113443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract_638139917571113443" xlink:to="us-gaap_EarningsPerShareBasic_638139917571113443" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638139917571113443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract_638139917571113443" xlink:to="us-gaap_EarningsPerShareDiluted_638139917571113443" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_638139917571123437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_638139917571123437" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638139917571123437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_638139917571123437" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638139917571123437" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638139917571123437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_638139917571123437" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638139917571123437" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="extended" xlink:title="00300 - Statement - Consolidated Statements of Stockholders' Equity" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638139917571123437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable_638139917571123437" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638139917571123437" xlink:to="us-gaap_StatementEquityComponentsAxis_638139917571133454" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638139917571133454" xlink:to="us-gaap_CommonStockMember_638139917571133454" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638139917571133454" xlink:to="us-gaap_AdditionalPaidInCapitalMember_638139917571133454" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638139917571133454" xlink:to="us-gaap_RetainedEarningsMember_638139917571133454" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638139917571133454" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_638139917571133454" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638139917571133454" xlink:to="us-gaap_EquityComponentDomain_638139917571133454" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638139917571123437" xlink:to="us-gaap_StatementLineItems_638139917571133454" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_StockholdersEquity_638139917571133454" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_SharesIssued_638139917571133454" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_StockIssuedDuringPeriodValueEquityLineOfCredit" xlink:label="hsdt_StockIssuedDuringPeriodValueEquityLineOfCredit_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="hsdt_StockIssuedDuringPeriodValueEquityLineOfCredit_638139917571133454" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_StockIssuedDuringPeriodSharesEquityLineOfCredit" xlink:label="hsdt_StockIssuedDuringPeriodSharesEquityLineOfCredit_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="hsdt_StockIssuedDuringPeriodSharesEquityLineOfCredit_638139917571133454" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_638139917571133454"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_638139917571133454" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638139917571143457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638139917571143457" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_638139917571143457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_638139917571143457" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_638139917571143457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_638139917571143457" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsShares" xlink:label="hsdt_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsShares_638139917571143457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="hsdt_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsShares_638139917571143457" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_StockIssuedDuringPeriodValueWarrantExercised" xlink:label="hsdt_StockIssuedDuringPeriodValueWarrantExercised_638139917571143457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="hsdt_StockIssuedDuringPeriodValueWarrantExercised_638139917571143457" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_StockIssuedDuringPeriodSharesWarrantExercised" xlink:label="hsdt_StockIssuedDuringPeriodSharesWarrantExercised_638139917571143457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="hsdt_StockIssuedDuringPeriodSharesWarrantExercised_638139917571143457" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_638139917571143457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_638139917571143457" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638139917571143457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638139917571143457" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_638139917571143457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_638139917571143457" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_638139917571143457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_638139917571143457" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_638139917571153443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_638139917571153443" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_638139917571153443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_638139917571153443" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_638139917571153443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_638139917571153443" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638139917571153443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638139917571153443" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638139917571153443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_NetIncomeLoss_638139917571153443" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638139917571153443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_StockholdersEquity_638139917571153443" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_638139917571153443"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638139917571133454" xlink:to="us-gaap_SharesIssued_638139917571153443" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00400 - Statement - Consolidated Statements of Cash Flows" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_638139917571163444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_ProfitLoss_638139917571163444" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_638139917571163444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_638139917571163444" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638139917571163444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_ShareBasedCompensation_638139917571163444" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_638139917571163444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_638139917571163444" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_638139917571163444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_638139917571163444" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation_638139917571163444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_Depreciation_638139917571163444" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_638139917571163444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_AmortizationOfIntangibleAssets_638139917571163444" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss_638139917571173260"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_GoodwillImpairmentLoss_638139917571173260" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_638139917571173260"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_638139917571173260" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown_638139917571173260"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_InventoryWriteDown_638139917571173260" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense_638139917571173260"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_OperatingLeaseExpense_638139917571173260" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_638139917571173260"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_638139917571173260" order="11" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638139917571173260"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638139917571173260" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_638139917571173260"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638139917571173260" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_638139917571173260" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_638139917571173260"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638139917571173260" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_638139917571173260" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories_638139917571183573"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638139917571173260" xlink:to="us-gaap_IncreaseDecreaseInInventories_638139917571183573" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638139917571183573"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638139917571173260" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638139917571183573" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_638139917571183573"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638139917571173260" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_638139917571183573" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_638139917571183573"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638139917571173260" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_638139917571183573" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_638139917571183573"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638139917571173260" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_638139917571183573" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_638139917571183573"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638139917571173260" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_638139917571183573" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638139917571183573"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638139917571163444" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638139917571183573" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638139917571183573"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638139917571183573" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638139917571193464"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638139917571183573" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638139917571193464" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_638139917571193464"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638139917571183573" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_638139917571193464" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopSoftware" xlink:label="us-gaap_PaymentsToDevelopSoftware_638139917571193464"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638139917571183573" xlink:to="us-gaap_PaymentsToDevelopSoftware_638139917571193464" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638139917571193464"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638139917571183573" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638139917571193464" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638139917571193464"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638139917571193464" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638139917571193464"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638139917571193464" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638139917571193464" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_638139917571203423"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638139917571193464" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_638139917571203423" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ProceedsFromExerciseOfWarrantsAndStockOptions" xlink:label="hsdt_ProceedsFromExerciseOfWarrantsAndStockOptions_638139917571203423"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638139917571193464" xlink:to="hsdt_ProceedsFromExerciseOfWarrantsAndStockOptions_638139917571203423" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638139917571203423"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638139917571193464" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638139917571203423" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_638139917571203423"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_638139917571203423" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_638139917571203423"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_638139917571203423" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_638139917571203423"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_638139917571203423" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6381399175712034231"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6381399175712034231" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_638139917571213425"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_638139917571213425" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDerivativeIssuanceCosts" xlink:label="us-gaap_PaymentsOfDerivativeIssuanceCosts_638139917571213425"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_638139917571213425" xlink:to="us-gaap_PaymentsOfDerivativeIssuanceCosts_638139917571213425" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:label="us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_638139917571213425"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_638139917571213425" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_638139917571213425"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_638139917571213425" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_638139917571213425" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_NonCashShareIssuanceCosts" xlink:label="hsdt_NonCashShareIssuanceCosts_638139917571213425"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_638139917571213425" xlink:to="hsdt_NonCashShareIssuanceCosts_638139917571213425" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ShareIssuanceCostsIncludedInAccountsPayableAndAccruedLiabilities" xlink:label="hsdt_ShareIssuanceCostsIncludedInAccountsPayableAndAccruedLiabilities_638139917571213425"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_638139917571213425" xlink:to="hsdt_ShareIssuanceCostsIncludedInAccountsPayableAndAccruedLiabilities_638139917571213425" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureDescriptionOfBusiness" xlink:type="extended" xlink:title="10101 - Disclosure - DESCRIPTION OF BUSINESS" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations_638139917571223432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations_638139917571223432" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureSignificantAccountingPolicies" xlink:type="extended" xlink:title="10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_638139917571223432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_638139917571223432" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureGoodwillImpairment" xlink:type="extended" xlink:title="10301 - Disclosure - GOODWILL IMPAIRMENT" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAbstract" xlink:label="us-gaap_GoodwillImpairedAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="us-gaap_GoodwillDisclosureTextBlock_638139917571223432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillImpairedAbstract" xlink:to="us-gaap_GoodwillDisclosureTextBlock_638139917571223432" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosures" xlink:type="extended" xlink:title="10401 - Disclosure - SUPPLEMENTAL BALANCE SHEET DISCLOSURES" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_SupplementalBalanceSheetDisclosuresAbstract" xlink:label="SupplementalBalanceSheetDisclosuresAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_638139917571233461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalBalanceSheetDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_638139917571233461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureLeases" xlink:type="extended" xlink:title="10501 - Disclosure - LEASES" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_638139917571233461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_638139917571233461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIntangibleAssets" xlink:type="extended" xlink:title="10601 - Disclosure - INTANGIBLE ASSETS" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_638139917571233461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_638139917571233461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureFairValueMeasurements" xlink:type="extended" xlink:title="10701 - Disclosure - FAIR VALUE MEASUREMENTS" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock_638139917571233461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock_638139917571233461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureCommonStockAndWarrants" xlink:type="extended" xlink:title="10801 - Disclosure - COMMON STOCK AND WARRANTS" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_638139917571243472"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_638139917571243472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensation" xlink:type="extended" xlink:title="10901 - Disclosure - STOCK-BASED COMPENSATION" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_638139917571243472"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_638139917571243472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureBasicAndDilutedLossPerShare" xlink:type="extended" xlink:title="11001 - Disclosure - BASIC AND DILUTED LOSS PER SHARE" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock_638139917571243472"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock_638139917571243472" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIncomeTaxes" xlink:type="extended" xlink:title="11101 - Disclosure - INCOME TAXES" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_638139917571253652"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_638139917571253652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureDefinedContributionPlan" xlink:type="extended" xlink:title="11201 - Disclosure - DEFINED CONTRIBUTION PLAN" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanAbstract" xlink:label="us-gaap_DefinedContributionPlanAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanTextBlock" xlink:label="us-gaap_DefinedContributionPlanTextBlock_638139917571253652"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanAbstract" xlink:to="us-gaap_DefinedContributionPlanTextBlock_638139917571253652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:type="extended" xlink:title="11301 - Disclosure - COMMITMENTS AND CONTINGENCIES" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_638139917571253652"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_638139917571253652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureEnterpriseWideDisclosures" xlink:type="extended" xlink:title="11401 - Disclosure - ENTERPRISE-WIDE DISCLOSURES" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_638139917571253652"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_638139917571253652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies" xlink:type="extended" xlink:title="20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock_638139917571263432" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_638139917571263432" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates_638139917571263432" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_RisksAndUncertaintiesPolicyTextBlock" xlink:label="hsdt_RisksAndUncertaintiesPolicyTextBlock_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="hsdt_RisksAndUncertaintiesPolicyTextBlock_638139917571263432" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_638139917571263432" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_638139917571263432" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk_638139917571263432" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638139917571263432" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_638139917571263432" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock_638139917571263432" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_638139917571263432"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_638139917571263432" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_638139917571273437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_638139917571273437" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeasesPolicyTextBlock" xlink:label="us-gaap_LessorLeasesPolicyTextBlock_638139917571273437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_LessorLeasesPolicyTextBlock_638139917571273437" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_638139917571273437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_638139917571273437" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_638139917571273437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_638139917571273437" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_638139917571273437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_638139917571273437" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_638139917571273437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_638139917571273437" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock_638139917571273437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock_638139917571273437" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_638139917571273437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_638139917571273437" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_638139917571273437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_638139917571273437" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresTables" xlink:type="extended" xlink:title="30403 - Disclosure - SUPPLEMENTAL BALANCE SHEET DISCLOSURES (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_SupplementalBalanceSheetDisclosuresAbstract" xlink:label="hsdt_SupplementalBalanceSheetDisclosuresAbstract_3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_638139917571285808"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_3" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_638139917571285808" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_638139917571285808"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_3" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_638139917571285808" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_638139917571285808"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_3" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_638139917571285808" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock" xlink:label="hsdt_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock_638139917571285808"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_3" xlink:to="hsdt_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock_638139917571285808" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureLeasesTables" xlink:type="extended" xlink:title="30503 - Disclosure - LEASES (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract_2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_LesseeOperatingLeaseInformationIncludingMaturityTableTextBlock" xlink:label="hsdt_LesseeOperatingLeaseInformationIncludingMaturityTableTextBlock_638139917571293501"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract_2" xlink:to="hsdt_LesseeOperatingLeaseInformationIncludingMaturityTableTextBlock_638139917571293501" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIntangibleAssetsTables" xlink:type="extended" xlink:title="30603 - Disclosure - INTANGIBLE ASSETS (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_638139917571293501"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_3" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_638139917571293501" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_638139917571293501"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_3" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_638139917571293501" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureCommonStockAndWarrantsTables" xlink:type="extended" xlink:title="30803 - Disclosure - COMMON STOCK AND WARRANTS (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ScheduleOfStockholdersEquityTable" xlink:label="hsdt_ScheduleOfStockholdersEquityTable_638139917571293501"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="hsdt_ScheduleOfStockholdersEquityTable_638139917571293501" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638139917571293501"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityTable_638139917571293501" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638139917571293501" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571303666"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638139917571293501" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571303666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_FebruaryTwoThousandTwentyOneOfferingMember" xlink:label="hsdt_FebruaryTwoThousandTwentyOneOfferingMember_638139917571303666"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571303666" xlink:to="hsdt_FebruaryTwoThousandTwentyOneOfferingMember_638139917571303666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_AugustTwoThousandTwentyTwoOfferingMember" xlink:label="hsdt_AugustTwoThousandTwentyTwoOfferingMember_638139917571303666"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571303666" xlink:to="hsdt_AugustTwoThousandTwentyTwoOfferingMember_638139917571303666" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ScheduleOfStockholdersEquityLineItems" xlink:label="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571303666"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityTable_638139917571293501" xlink:to="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571303666" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ScheduleOfWeightedAverageAssumptionsUsedForFairValueOfWarrantsTableTextBlock" xlink:label="hsdt_ScheduleOfWeightedAverageAssumptionsUsedForFairValueOfWarrantsTableTextBlock_638139917571303666"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571303666" xlink:to="hsdt_ScheduleOfWeightedAverageAssumptionsUsedForFairValueOfWarrantsTableTextBlock_638139917571303666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensationTables" xlink:type="extended" xlink:title="30903 - Disclosure - STOCK-BASED COMPENSATION (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_638139917571303666"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_638139917571303666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_638139917571303666"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_638139917571303666" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_638139917571303666"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_638139917571303666" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_638139917571303666"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_638139917571303666" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureBasicAndDilutedLossPerShareTables" xlink:type="extended" xlink:title="31003 - Disclosure - BASIC AND DILUTED LOSS PER SHARE (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract_2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638139917571313508"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_2" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638139917571313508" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_638139917571313508"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_2" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_638139917571313508" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIncomeTaxesTables" xlink:type="extended" xlink:title="31103 - Disclosure - INCOME TAXES (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_638139917571313508"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_638139917571313508" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_638139917571313508"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_638139917571313508" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_638139917571313508"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_638139917571313508" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_638139917571313508"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_638139917571313508" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:label="us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_638139917571313508"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_638139917571313508" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureEnterpriseWideDisclosuresTables" xlink:type="extended" xlink:title="31403 - Disclosure - ENTERPRISE-WIDE DISCLOSURES (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract_1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_638139917571323463"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract_1" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_638139917571323463" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureDescriptionOfBusinessDetails" xlink:type="extended" xlink:title="40101 - Disclosure - DESCRIPTION OF BUSINESS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638139917571323463"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638139917571323463" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638139917571323463"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OperatingIncomeLoss_638139917571323463" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638139917571323463"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638139917571323463" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638139917571333475" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended" xlink:title="40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ScheduleOfSignificantAccountingPoliciesTable" xlink:label="hsdt_ScheduleOfSignificantAccountingPoliciesTable_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="hsdt_ScheduleOfSignificantAccountingPoliciesTable_638139917571333475" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfSignificantAccountingPoliciesTable_638139917571333475" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638139917571333475" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638139917571333475" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_638139917571333475" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638139917571333475" xlink:to="us-gaap_FurnitureAndFixturesMember_638139917571333475" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638139917571333475" xlink:to="us-gaap_EquipmentMember_638139917571333475" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ComputerSoftwareAndHardwareMember" xlink:label="hsdt_ComputerSoftwareAndHardwareMember_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638139917571333475" xlink:to="hsdt_ComputerSoftwareAndHardwareMember_638139917571333475" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfSignificantAccountingPoliciesTable_638139917571333475" xlink:to="srt_RangeAxis_638139917571333475" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638139917571333475" xlink:to="srt_RangeMember_638139917571333475" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638139917571333475" xlink:to="srt_MinimumMember_638139917571333475" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638139917571333475"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638139917571333475" xlink:to="srt_MaximumMember_638139917571333475" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638139917571343457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638139917571333475" xlink:to="srt_MaximumMember_638139917571343457" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ScheduleOfSignificantAccountingPoliciesLineItems" xlink:label="hsdt_ScheduleOfSignificantAccountingPoliciesLineItems_638139917571343457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfSignificantAccountingPoliciesTable_638139917571333475" xlink:to="hsdt_ScheduleOfSignificantAccountingPoliciesLineItems_638139917571343457" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_638139917571343457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfSignificantAccountingPoliciesLineItems_638139917571343457" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_638139917571343457" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments_638139917571343457"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfSignificantAccountingPoliciesLineItems_638139917571343457" xlink:to="us-gaap_NumberOfOperatingSegments_638139917571343457" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureGoodwillImpairmentDetails" xlink:type="extended" xlink:title="40301 - Disclosure - GOODWILL IMPAIRMENT (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAbstract" xlink:label="us-gaap_GoodwillImpairedAbstract_1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits" xlink:label="us-gaap_NumberOfReportingUnits_638139917571403496"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillImpairedAbstract_1" xlink:to="us-gaap_NumberOfReportingUnits_638139917571403496" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss_638139917571403496"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillImpairedAbstract_1" xlink:to="us-gaap_GoodwillImpairmentLoss_638139917571403496" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresAccountsReceivableNetDetails" xlink:type="extended" xlink:title="40401 - Disclosure - SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Accounts receivable, net (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_SupplementalBalanceSheetDisclosuresAbstract" xlink:label="hsdt_SupplementalBalanceSheetDisclosuresAbstract_5"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivablesPastDueTable" xlink:label="us-gaap_ScheduleOfFinancingReceivablesPastDueTable_638139917571403496"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_5" xlink:to="us-gaap_ScheduleOfFinancingReceivablesPastDueTable_638139917571403496" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis_638139917571403496"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFinancingReceivablesPastDueTable_638139917571403496" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueAxis_638139917571403496" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain_638139917571403496"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis_638139917571403496" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain_638139917571403496" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialAssetPastDueMember" xlink:label="us-gaap_FinancialAssetPastDueMember_638139917571403496"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain_638139917571403496" xlink:to="us-gaap_FinancialAssetPastDueMember_638139917571403496" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638139917571403496"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFinancingReceivablesPastDueTable_638139917571403496" xlink:to="srt_RangeAxis_638139917571403496" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638139917571403496"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638139917571403496" xlink:to="srt_RangeMember_638139917571403496" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638139917571403496"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638139917571403496" xlink:to="srt_MaximumMember_638139917571403496" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" xlink:label="us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_638139917571413507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFinancingReceivablesPastDueTable_638139917571403496" xlink:to="us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_638139917571413507" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_638139917571413507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_638139917571413507" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_638139917571413507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_638139917571413507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_638139917571413507" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_638139917571413507" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresInventoryDetails" xlink:type="extended" xlink:title="40402 - Disclosure - SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Inventory (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_SupplementalBalanceSheetDisclosuresAbstract" xlink:label="SupplementalBalanceSheetDisclosuresAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract" xlink:label="us-gaap_InventoryNetAbstract_638139917571413507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalBalanceSheetDisclosuresAbstract" xlink:to="us-gaap_InventoryNetAbstract_638139917571413507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials_638139917571413507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract_638139917571413507" xlink:to="us-gaap_InventoryRawMaterials_638139917571413507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess_638139917571413507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract_638139917571413507" xlink:to="us-gaap_InventoryWorkInProcess_638139917571413507" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods_638139917571413507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract_638139917571413507" xlink:to="us-gaap_InventoryFinishedGoods_638139917571413507" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross_638139917571413507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract_638139917571413507" xlink:to="us-gaap_InventoryGross_638139917571413507" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves_638139917571413507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract_638139917571413507" xlink:to="us-gaap_InventoryValuationReserves_638139917571413507" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_638139917571413507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract_638139917571413507" xlink:to="us-gaap_InventoryNet_638139917571413507" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_InventoryReservesChargedAgainstWorkInProcessInventory" xlink:label="hsdt_InventoryReservesChargedAgainstWorkInProcessInventory_638139917571423461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract_638139917571413507" xlink:to="hsdt_InventoryReservesChargedAgainstWorkInProcessInventory_638139917571423461" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="extended" xlink:title="40403 - Disclosure - SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Prepaid expenses and other current assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_SupplementalBalanceSheetDisclosuresAbstract" xlink:label="hsdt_SupplementalBalanceSheetDisclosuresAbstract_8"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent_638139917571423461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_8" xlink:to="us-gaap_PrepaidExpenseCurrent_638139917571423461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_InventoryRelatedAssetsCurrent" xlink:label="hsdt_InventoryRelatedAssetsCurrent_638139917571423461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_8" xlink:to="hsdt_InventoryRelatedAssetsCurrent_638139917571423461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_638139917571423461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_8" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_638139917571423461" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresPropertyAndEquipmentNetDetails" xlink:type="extended" xlink:title="40404 - Disclosure - SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Property and equipment, net (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_SupplementalBalanceSheetDisclosuresAbstract" xlink:label="hsdt_SupplementalBalanceSheetDisclosuresAbstract_7"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638139917571423461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_7" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638139917571423461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638139917571423461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638139917571423461" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638139917571423461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_638139917571423461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638139917571423461" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_638139917571423461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember_638139917571433784"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638139917571423461" xlink:to="us-gaap_FurnitureAndFixturesMember_638139917571433784" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember_638139917571433784"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638139917571423461" xlink:to="us-gaap_EquipmentMember_638139917571433784" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ComputerSoftwareAndHardwareMember" xlink:label="hsdt_ComputerSoftwareAndHardwareMember_638139917571433784"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638139917571423461" xlink:to="hsdt_ComputerSoftwareAndHardwareMember_638139917571433784" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_638139917571433784"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638139917571423461" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_638139917571433784" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_638139917571433784"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638139917571433784" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_638139917571433784" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_638139917571433784"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638139917571433784" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_638139917571433784" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_638139917571433784"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638139917571433784" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_638139917571433784" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresAccruedExpensesDetails" xlink:type="extended" xlink:title="40405 - Disclosure - SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Accrued Expenses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_SupplementalBalanceSheetDisclosuresAbstract" xlink:label="hsdt_SupplementalBalanceSheetDisclosuresAbstract_2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract_638139917571433784"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_2" xlink:to="us-gaap_PayablesAndAccrualsAbstract_638139917571433784" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="us-gaap_AccruedInsuranceCurrent_638139917571433784"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract_638139917571433784" xlink:to="us-gaap_AccruedInsuranceCurrent_638139917571433784" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent_638139917571443512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract_638139917571433784" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent_638139917571443512" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_638139917571443512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract_638139917571433784" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_638139917571443512" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_AccruedFranchiseFeeCurrent" xlink:label="hsdt_AccruedFranchiseFeeCurrent_638139917571443512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract_638139917571433784" xlink:to="hsdt_AccruedFranchiseFeeCurrent_638139917571443512" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent" xlink:label="us-gaap_RestructuringReserveCurrent_638139917571443512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract_638139917571433784" xlink:to="us-gaap_RestructuringReserveCurrent_638139917571443512" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_638139917571443512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract_638139917571433784" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_638139917571443512" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_AccruedAndOtherCurrentLiabilities." xlink:label="hsdt_AccruedAndOtherCurrentLiabilities._638139917571443512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract_638139917571433784" xlink:to="hsdt_AccruedAndOtherCurrentLiabilities._638139917571443512" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureSupplementalBalanceSheetDisclosuresDeferredRevenueDetails" xlink:type="extended" xlink:title="40406 - Disclosure - SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Deferred Revenue (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_SupplementalBalanceSheetDisclosuresAbstract" xlink:label="hsdt_SupplementalBalanceSheetDisclosuresAbstract_4"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_638139917571443512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_SupplementalBalanceSheetDisclosuresAbstract_4" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_638139917571443512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_638139917571443512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_638139917571443512" xlink:to="srt_CounterpartyNameAxis_638139917571443512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_638139917571443512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_638139917571443512" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_638139917571443512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_HealthTechConnexIncorporationMember" xlink:label="hsdt_HealthTechConnexIncorporationMember_638139917571443512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638139917571443512" xlink:to="hsdt_HealthTechConnexIncorporationMember_638139917571443512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638139917571453615"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_638139917571443512" xlink:to="us-gaap_TypeOfArrangementAxis_638139917571453615" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638139917571453615"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638139917571453615" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638139917571453615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ClinicalResearchAndCoPromotionAgreementMember" xlink:label="hsdt_ClinicalResearchAndCoPromotionAgreementMember_638139917571453615"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638139917571453615" xlink:to="hsdt_ClinicalResearchAndCoPromotionAgreementMember_638139917571453615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ExclusiveDistributionAgreementMember" xlink:label="hsdt_ExclusiveDistributionAgreementMember_638139917571453615"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638139917571453615" xlink:to="hsdt_ExclusiveDistributionAgreementMember_638139917571453615" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_638139917571453615"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_638139917571443512" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_638139917571453615" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueAbstract" xlink:label="us-gaap_DeferredRevenueAbstract_638139917571453615"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_638139917571453615" xlink:to="us-gaap_DeferredRevenueAbstract_638139917571453615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_UpFrontPaymentReceived" xlink:label="hsdt_UpFrontPaymentReceived_638139917571453615"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_UpFrontPaymentReceived_638139917571453615" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ExclusivityRightGrantedValue" xlink:label="hsdt_ExclusivityRightGrantedValue_638139917571453615"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_ExclusivityRightGrantedValue_638139917571453615" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_DeferredLicenseRevenueNotYetRecognized" xlink:label="hsdt_DeferredLicenseRevenueNotYetRecognized_638139917571453615"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_DeferredLicenseRevenueNotYetRecognized_638139917571453615" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_DeferredRevenueProductSales" xlink:label="hsdt_DeferredRevenueProductSales_638139917571453615"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_DeferredRevenueProductSales_638139917571453615" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_DeferredRevenueRecognizedProductSales" xlink:label="hsdt_DeferredRevenueRecognizedProductSales_638139917571463662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_DeferredRevenueRecognizedProductSales_638139917571463662" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_NumberOfDevicesResultedInRecognitionOfRevenue" xlink:label="hsdt_NumberOfDevicesResultedInRecognitionOfRevenue_638139917571463662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_NumberOfDevicesResultedInRecognitionOfRevenue_638139917571463662" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_LicenseRevenueTermOfAgreement" xlink:label="hsdt_LicenseRevenueTermOfAgreement_638139917571463662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_LicenseRevenueTermOfAgreement_638139917571463662" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ExclusivityRightsInitialTerm" xlink:label="hsdt_ExclusivityRightsInitialTerm_638139917571463662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_ExclusivityRightsInitialTerm_638139917571463662" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ExclusivityRightsNumberOfAdditionalTerms" xlink:label="hsdt_ExclusivityRightsNumberOfAdditionalTerms_638139917571463662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_ExclusivityRightsNumberOfAdditionalTerms_638139917571463662" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ExclusivityRightsAdditionalTerm" xlink:label="hsdt_ExclusivityRightsAdditionalTerm_638139917571463662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_ExclusivityRightsAdditionalTerm_638139917571463662" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ExclusivityRightsPeriodOfWrittenNoticeForRenewal" xlink:label="hsdt_ExclusivityRightsPeriodOfWrittenNoticeForRenewal_638139917571463662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueAbstract_638139917571453615" xlink:to="hsdt_ExclusivityRightsPeriodOfWrittenNoticeForRenewal_638139917571463662" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureLeasesDetails" xlink:type="extended" xlink:title="40501 - Disclosure - LEASES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract_1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_NumberOfOperatingLeases" xlink:label="hsdt_NumberOfOperatingLeases_638139917571473510"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract_1" xlink:to="hsdt_NumberOfOperatingLeases_638139917571473510" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_638139917571473510"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract_1" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_638139917571473510" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost_638139917571473510"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract_1" xlink:to="us-gaap_OperatingLeaseCost_638139917571473510" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638139917571473510"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract_1" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638139917571473510" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638139917571473510"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638139917571473510" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638139917571473510" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_638139917571473510"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638139917571473510" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_638139917571473510" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_638139917571473510"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638139917571473510" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_638139917571473510" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_638139917571473510"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638139917571473510" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_638139917571473510" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_638139917571473510"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638139917571473510" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_638139917571473510" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_638139917571473510"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_638139917571473510" xlink:to="us-gaap_OperatingLeaseLiability_638139917571473510" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="us-gaap_LesseeOperatingLeaseDescriptionAbstract_638139917571483533"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract_1" xlink:to="us-gaap_LesseeOperatingLeaseDescriptionAbstract_638139917571483533" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_638139917571483533"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseDescriptionAbstract_638139917571483533" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_638139917571483533" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_638139917571503495"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseDescriptionAbstract_638139917571483533" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_638139917571503495" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIntangibleAssetsSummaryDetails" xlink:type="extended" xlink:title="40601 - Disclosure - INTANGIBLE ASSETS - Summary (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638139917571503495"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_1" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638139917571503495" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638139917571503495"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638139917571503495" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638139917571503495" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638139917571503495"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638139917571503495" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638139917571503495" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_AcquiredProprietarySoftwareMember" xlink:label="hsdt_AcquiredProprietarySoftwareMember_638139917571503495"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638139917571503495" xlink:to="hsdt_AcquiredProprietarySoftwareMember_638139917571503495" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ReacquiredRightsMember" xlink:label="hsdt_ReacquiredRightsMember_638139917571503495"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638139917571503495" xlink:to="hsdt_ReacquiredRightsMember_638139917571503495" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember_638139917571503495"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638139917571503495" xlink:to="us-gaap_SoftwareDevelopmentMember_638139917571503495" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_638139917571503495"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638139917571503495" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_638139917571503495" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_638139917571513579"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638139917571503495" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_638139917571513579" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_638139917571513579"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638139917571503495" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_638139917571513579" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638139917571513579"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638139917571503495" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638139917571513579" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_638139917571513579"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638139917571503495" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_638139917571513579" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIntangibleAssetsEstimatedAmortizationExpenseDetails" xlink:type="extended" xlink:title="40602 - Disclosure - INTANGIBLE ASSETS - Estimated Amortization Expense (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_638139917571513579"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2" xlink:to="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_638139917571513579" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_638139917571513579"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_638139917571513579" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_638139917571513579" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_638139917571513579"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_638139917571513579" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_638139917571513579" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_638139917571513579"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_638139917571513579" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_638139917571513579" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureCommonStockAndWarrantsAdditionalInformationDetails" xlink:type="extended" xlink:title="40801 - Disclosure - COMMON STOCK AND WARRANTS - Additional Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ScheduleOfStockholdersEquityTable" xlink:label="hsdt_ScheduleOfStockholdersEquityTable_638139917571523484"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="hsdt_ScheduleOfStockholdersEquityTable_638139917571523484" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638139917571523484"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityTable_638139917571523484" xlink:to="us-gaap_StatementClassOfStockAxis_638139917571523484" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638139917571523484"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638139917571523484" xlink:to="us-gaap_ClassOfStockDomain_638139917571523484" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_638139917571523484"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638139917571523484" xlink:to="us-gaap_CommonClassAMember_638139917571523484" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638139917571523484"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityTable_638139917571523484" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638139917571523484" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571523484"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638139917571523484" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571523484" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_AugustTwoThousandTwentyTwoOfferingMember" xlink:label="hsdt_AugustTwoThousandTwentyTwoOfferingMember_638139917571523484"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571523484" xlink:to="hsdt_AugustTwoThousandTwentyTwoOfferingMember_638139917571523484" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_638139917571523484"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571523484" xlink:to="us-gaap_OverAllotmentOptionMember_638139917571523484" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_FebruaryTwoThousandTwentyOneOfferingMember" xlink:label="hsdt_FebruaryTwoThousandTwentyOneOfferingMember_638139917571523484"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571523484" xlink:to="hsdt_FebruaryTwoThousandTwentyOneOfferingMember_638139917571523484" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_NovemberTwoThousandTwentyOneOfferingMember" xlink:label="hsdt_NovemberTwoThousandTwentyOneOfferingMember_638139917571523484"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571523484" xlink:to="hsdt_NovemberTwoThousandTwentyOneOfferingMember_638139917571523484" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_PublicOfferingMember" xlink:label="hsdt_PublicOfferingMember_638139917571533493"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571523484" xlink:to="hsdt_PublicOfferingMember_638139917571533493" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_638139917571533493"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityTable_638139917571523484" xlink:to="us-gaap_StatementEquityComponentsAxis_638139917571533493" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_638139917571533493"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638139917571533493" xlink:to="us-gaap_EquityComponentDomain_638139917571533493" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_638139917571533493"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_638139917571533493" xlink:to="us-gaap_CommonStockMember_638139917571533493" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_638139917571533493"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_638139917571533493" xlink:to="us-gaap_AdditionalPaidInCapitalMember_638139917571533493" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638139917571533493"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityTable_638139917571523484" xlink:to="us-gaap_TypeOfArrangementAxis_638139917571533493" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638139917571533493"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638139917571533493" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638139917571533493" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_LincolnParkPurchaseAgreementMember" xlink:label="hsdt_LincolnParkPurchaseAgreementMember_638139917571533493"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638139917571533493" xlink:to="hsdt_LincolnParkPurchaseAgreementMember_638139917571533493" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_638139917571533493"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityTable_638139917571523484" xlink:to="srt_CounterpartyNameAxis_638139917571533493" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_638139917571543507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_638139917571533493" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_638139917571543507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_LincolnParkCapitalFundLLCMember" xlink:label="hsdt_LincolnParkCapitalFundLLCMember_638139917571543507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638139917571543507" xlink:to="hsdt_LincolnParkCapitalFundLLCMember_638139917571543507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638139917571543507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityTable_638139917571523484" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638139917571543507" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638139917571543507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638139917571543507" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638139917571543507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_CommonStockWarrantsMember" xlink:label="hsdt_CommonStockWarrantsMember_638139917571543507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638139917571543507" xlink:to="hsdt_CommonStockWarrantsMember_638139917571543507" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_PublicWarrantsMember" xlink:label="hsdt_PublicWarrantsMember_638139917571543507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638139917571543507" xlink:to="hsdt_PublicWarrantsMember_638139917571543507" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_PreFundedWarrantsMember" xlink:label="hsdt_PreFundedWarrantsMember_638139917571543507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638139917571543507" xlink:to="hsdt_PreFundedWarrantsMember_638139917571543507" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ScheduleOfStockholdersEquityLineItems" xlink:label="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityTable_638139917571523484" xlink:to="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_638139917571553499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_638139917571553499" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_638139917571553499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="us-gaap_SaleOfStockPricePerShare_638139917571553499" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ProceedsFromIssuanceOfCommonStockNet" xlink:label="hsdt_ProceedsFromIssuanceOfCommonStockNet_638139917571553499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="hsdt_ProceedsFromIssuanceOfCommonStockNet_638139917571553499" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_FairValueOfWarrantsAtIssuance" xlink:label="hsdt_FairValueOfWarrantsAtIssuance_638139917571553499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="hsdt_FairValueOfWarrantsAtIssuance_638139917571553499" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_638139917571553499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_638139917571553499" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638139917571553499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638139917571553499" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_StockIssuedDuringPeriodSharesEquityLineOfCredit" xlink:label="hsdt_StockIssuedDuringPeriodSharesEquityLineOfCredit_638139917571553499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="hsdt_StockIssuedDuringPeriodSharesEquityLineOfCredit_638139917571553499" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ClassOfWarrantsOrRightExpirationPeriod" xlink:label="hsdt_ClassOfWarrantsOrRightExpirationPeriod_638139917571563507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="hsdt_ClassOfWarrantsOrRightExpirationPeriod_638139917571563507" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638139917571563507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_638139917571563507" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_638139917571563507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_638139917571563507" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_FairValueOfCommitmentFeeAmount" xlink:label="hsdt_FairValueOfCommitmentFeeAmount_638139917571563507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="hsdt_FairValueOfCommitmentFeeAmount_638139917571563507" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_SaleOfStockCombinedOfferingPricePerShare" xlink:label="hsdt_SaleOfStockCombinedOfferingPricePerShare_638139917571563507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="hsdt_SaleOfStockCombinedOfferingPricePerShare_638139917571563507" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_SaleOfStockPreFundedWarrantsAndAccompanyingPublicWarrantsPricePerShare" xlink:label="hsdt_SaleOfStockPreFundedWarrantsAndAccompanyingPublicWarrantsPricePerShare_638139917571563507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="hsdt_SaleOfStockPreFundedWarrantsAndAccompanyingPublicWarrantsPricePerShare_638139917571563507" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ProceedsFromNewIssuanceAllocatedBetweenEquityAndDerivativeLiability" xlink:label="hsdt_ProceedsFromNewIssuanceAllocatedBetweenEquityAndDerivativeLiability_638139917571563507"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="hsdt_ProceedsFromNewIssuanceAllocatedBetweenEquityAndDerivativeLiability_638139917571563507" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_CashPaidShareIssuanceCostsAllocatedBetweenEquityAndDerivativeLiability" xlink:label="hsdt_CashPaidShareIssuanceCostsAllocatedBetweenEquityAndDerivativeLiability_638139917571573490"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="hsdt_CashPaidShareIssuanceCostsAllocatedBetweenEquityAndDerivativeLiability_638139917571573490" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_638139917571573490"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_638139917571573490" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_638139917571573490"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_638139917571573490" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_638139917571573490"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_638139917571573490" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDerivativeIssuanceCosts" xlink:label="us-gaap_PaymentsOfDerivativeIssuanceCosts_638139917571573490"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ScheduleOfStockholdersEquityLineItems_638139917571543507" xlink:to="us-gaap_PaymentsOfDerivativeIssuanceCosts_638139917571573490" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureCommonStockAndWarrantsSummaryOfWeightedAverageAssumptionsUsedInEstimatingFairValueOfWarrantsDetails" xlink:type="extended" xlink:title="40802 - Disclosure - COMMON STOCK AND WARRANTS - Summary of Weighted Average Assumptions Used in Estimating Fair Value of Warrants (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638139917571583653"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638139917571583653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis_638139917571583653"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638139917571583653" xlink:to="us-gaap_MeasurementInputTypeAxis_638139917571583653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_638139917571583653"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis_638139917571583653" xlink:to="us-gaap_MeasurementInputTypeDomain_638139917571583653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember_638139917571583653"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638139917571583653" xlink:to="us-gaap_MeasurementInputSharePriceMember_638139917571583653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember_638139917571583653"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638139917571583653" xlink:to="us-gaap_MeasurementInputExercisePriceMember_638139917571583653" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember_638139917571583653"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638139917571583653" xlink:to="us-gaap_MeasurementInputExpectedTermMember_638139917571583653" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_638139917571593561"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638139917571583653" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_638139917571593561" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_638139917571593561"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638139917571583653" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_638139917571593561" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_638139917571593561"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638139917571583653" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_638139917571593561" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638139917571593561"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638139917571583653" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638139917571593561" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571593561"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638139917571593561" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571593561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_FebruaryTwoThousandTwentyOneOfferingMember" xlink:label="hsdt_FebruaryTwoThousandTwentyOneOfferingMember_638139917571593561"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571593561" xlink:to="hsdt_FebruaryTwoThousandTwentyOneOfferingMember_638139917571593561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_AugustTwoThousandTwentyTwoOfferingMember" xlink:label="hsdt_AugustTwoThousandTwentyTwoOfferingMember_638139917571593561"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571593561" xlink:to="hsdt_AugustTwoThousandTwentyTwoOfferingMember_638139917571593561" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis_638139917571593561"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638139917571583653" xlink:to="us-gaap_FinancialInstrumentAxis_638139917571593561" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638139917571593561"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis_638139917571593561" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638139917571593561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember_638139917571593561"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_638139917571593561" xlink:to="us-gaap_WarrantMember_638139917571593561" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis_638139917571603505"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638139917571583653" xlink:to="us-gaap_FairValueByLiabilityClassAxis_638139917571603505" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_638139917571603505"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis_638139917571603505" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_638139917571603505" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_638139917571603505"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_638139917571603505" xlink:to="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_638139917571603505" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638139917571603505"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638139917571583653" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638139917571603505" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_638139917571603505"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638139917571603505" xlink:to="us-gaap_SharePrice_638139917571603505" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638139917571603505"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638139917571603505" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638139917571603505" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_638139917571603505"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638139917571603505" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput_638139917571603505" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_638139917571603505"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638139917571603505" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_638139917571603505" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_638139917571613437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638139917571603505" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_638139917571613437" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingValuationTechniqueExtensibleList" xlink:label="us-gaap_WarrantsAndRightsOutstandingValuationTechniqueExtensibleList_638139917571613437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638139917571603505" xlink:to="us-gaap_WarrantsAndRightsOutstandingValuationTechniqueExtensibleList_638139917571613437" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTypeExtensibleList" xlink:label="us-gaap_WarrantsAndRightsOutstandingTypeExtensibleList_638139917571613437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638139917571603505" xlink:to="us-gaap_WarrantsAndRightsOutstandingTypeExtensibleList_638139917571613437" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureCommonStockAndWarrantsSummaryOfWarrantActivityDetails" xlink:type="extended" xlink:title="40803 - Disclosure - COMMON STOCK AND WARRANTS - Summary of Warrant Activity (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable_638139917571613437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable_638139917571613437" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638139917571613437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638139917571613437" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638139917571613437" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571613437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638139917571613437" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571613437" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_PublicOfferingMember" xlink:label="hsdt_PublicOfferingMember_638139917571613437"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571613437" xlink:to="hsdt_PublicOfferingMember_638139917571613437" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638139917571613437" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_638139917571623512" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_638139917571623512" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_638139917571623512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_CommonStockWarrantsMember" xlink:label="hsdt_CommonStockWarrantsMember_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638139917571623512" xlink:to="hsdt_CommonStockWarrantsMember_638139917571623512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_PublicWarrantsMember" xlink:label="hsdt_PublicWarrantsMember_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638139917571623512" xlink:to="hsdt_PublicWarrantsMember_638139917571623512" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_PreFundedWarrantsMember" xlink:label="hsdt_PreFundedWarrantsMember_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_638139917571623512" xlink:to="hsdt_PreFundedWarrantsMember_638139917571623512" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable_638139917571613437" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_638139917571623512" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ClassOfWarrantOrRightExpired" xlink:label="hsdt_ClassOfWarrantOrRightExpired_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638139917571623512" xlink:to="hsdt_ClassOfWarrantOrRightExpired_638139917571623512" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ClassOfWarrantOrRightExercised" xlink:label="hsdt_ClassOfWarrantOrRightExercised_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638139917571623512" xlink:to="hsdt_ClassOfWarrantOrRightExercised_638139917571623512" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ClassOfWarrantsOrRightExpirationPeriod" xlink:label="hsdt_ClassOfWarrantsOrRightExpirationPeriod_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638139917571623512" xlink:to="hsdt_ClassOfWarrantsOrRightExpirationPeriod_638139917571623512" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638139917571623512" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_638139917571623512" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638139917571623512"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638139917571623512" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638139917571623512" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_638139917571633499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems_638139917571623512" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_638139917571633499" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="extended" xlink:title="40901 - Disclosure - STOCK-BASED COMPENSATION - Additional Information- (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571633499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571633499" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_638139917571633499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571633499" xlink:to="us-gaap_PlanNameAxis_638139917571633499" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_638139917571633499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_638139917571633499" xlink:to="us-gaap_PlanNameDomain_638139917571633499" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_TwoThousandTwentyOneInducementPlanMember" xlink:label="hsdt_TwoThousandTwentyOneInducementPlanMember_638139917571633499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638139917571633499" xlink:to="hsdt_TwoThousandTwentyOneInducementPlanMember_638139917571633499" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_EquityIncentive2022PlanMember" xlink:label="hsdt_EquityIncentive2022PlanMember_638139917571633499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638139917571633499" xlink:to="hsdt_EquityIncentive2022PlanMember_638139917571633499" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638139917571633499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571633499" xlink:to="us-gaap_AwardTypeAxis_638139917571633499" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571633499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638139917571633499" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571633499" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_EmployeeAndDirectorStockOptionsMember" xlink:label="hsdt_EmployeeAndDirectorStockOptionsMember_638139917571633499"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571633499" xlink:to="hsdt_EmployeeAndDirectorStockOptionsMember_638139917571633499" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember_638139917571643444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571633499" xlink:to="us-gaap_PerformanceSharesMember_638139917571643444" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_638139917571643444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571633499" xlink:to="srt_TitleOfIndividualAxis_638139917571643444" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_638139917571643444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis_638139917571643444" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_638139917571643444" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefOperatingOfficerMember" xlink:label="srt_ChiefOperatingOfficerMember_638139917571643444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_638139917571643444" xlink:to="srt_ChiefOperatingOfficerMember_638139917571643444" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638139917571643444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571633499" xlink:to="srt_RangeAxis_638139917571643444" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638139917571643444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638139917571643444" xlink:to="srt_RangeMember_638139917571643444" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638139917571643444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638139917571643444" xlink:to="srt_MinimumMember_638139917571643444" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638139917571643444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638139917571643444" xlink:to="srt_MaximumMember_638139917571643444" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638139917571643444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571633499" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638139917571643444" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571643444"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638139917571643444" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571643444" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_AugustTwoThousandTwentyTwoOfferingMember" xlink:label="hsdt_AugustTwoThousandTwentyTwoOfferingMember_638139917571653478"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571643444" xlink:to="hsdt_AugustTwoThousandTwentyTwoOfferingMember_638139917571653478" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571633499" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_MaximumNumberOfSharesOfCommonStockThatMayBeIssuedOnExerciseOfIncentiveStockOptions" xlink:label="hsdt_MaximumNumberOfSharesOfCommonStockThatMayBeIssuedOnExerciseOfIncentiveStockOptions_638139917571653478"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" xlink:to="hsdt_MaximumNumberOfSharesOfCommonStockThatMayBeIssuedOnExerciseOfIncentiveStockOptions_638139917571653478" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_638139917571653478"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_638139917571653478" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_638139917571653478"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_638139917571653478" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ShareBasedCompensationAnnualIncreaseInAuthorizedSharesAsPercentageOfFullyDilutedSharesOfCommonStockOutstanding" xlink:label="hsdt_ShareBasedCompensationAnnualIncreaseInAuthorizedSharesAsPercentageOfFullyDilutedSharesOfCommonStockOutstanding_638139917571653478"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" xlink:to="hsdt_ShareBasedCompensationAnnualIncreaseInAuthorizedSharesAsPercentageOfFullyDilutedSharesOfCommonStockOutstanding_638139917571653478" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_638139917571653478"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_638139917571653478" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_638139917571663428"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_638139917571663428" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedVolatilitiesAssumptionTradingHistoryPeriod" xlink:label="hsdt_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedVolatilitiesAssumptionTradingHistoryPeriod_638139917571663428"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" xlink:to="hsdt_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedVolatilitiesAssumptionTradingHistoryPeriod_638139917571663428" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_638139917571663428"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_638139917571663428" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_638139917571663428"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_638139917571663428" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_638139917571663428"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571653478" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_638139917571663428" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensationFairValueAssumptionsDetails" xlink:type="extended" xlink:title="40902 - Disclosure - STOCK-BASED COMPENSATION - Fair Value Assumptions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571663428"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571663428" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638139917571673441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571663428" xlink:to="us-gaap_AwardTypeAxis_638139917571673441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571673441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638139917571673441" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571673441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638139917571673441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571673441" xlink:to="us-gaap_EmployeeStockOptionMember_638139917571673441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_638139917571673441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571663428" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_638139917571673441" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571673441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_638139917571673441" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571673441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_FebruaryTwoThousandTwentyOneOfferingMember" xlink:label="hsdt_FebruaryTwoThousandTwentyOneOfferingMember_638139917571673441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_638139917571673441" xlink:to="hsdt_FebruaryTwoThousandTwentyOneOfferingMember_638139917571673441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571673441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571663428" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571673441" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_638139917571673441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571673441" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_638139917571673441" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_638139917571673441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571673441" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_638139917571673441" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_638139917571673441"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571673441" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_638139917571673441" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_638139917571683662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571673441" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_638139917571683662" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_638139917571683662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571673441" xlink:to="us-gaap_SharePrice_638139917571683662" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValuePerShare" xlink:label="hsdt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValuePerShare_638139917571683662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571673441" xlink:to="hsdt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValuePerShare_638139917571683662" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCompanySStockOptionActivityDetails" xlink:type="extended" xlink:title="40903 - Disclosure - STOCK-BASED COMPENSATION - Summary of Company's Stock Option Activity (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_638139917571683662"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_638139917571683662" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638139917571693294" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_638139917571693294" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_638139917571693294" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_638139917571693294" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_638139917571693294" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_638139917571693294" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_638139917571693294" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_638139917571693294" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_638139917571693294" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6381399175716932941"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6381399175716932941" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_638139917571693294" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_638139917571693294"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_638139917571693294" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_638139917571703461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_638139917571703461" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensationOtherAwardsDetails" xlink:type="extended" xlink:title="40904 - Disclosure - STOCK-BASED COMPENSATION - Other Awards (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571703461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571703461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638139917571703461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571703461" xlink:to="us-gaap_AwardTypeAxis_638139917571703461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571703461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638139917571703461" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571703461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_638139917571703461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571703461" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_638139917571703461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571703461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638139917571703461" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571703461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638139917571703461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571703461" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638139917571703461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_638139917571703461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571703461" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_638139917571703461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_638139917571713451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571703461" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_638139917571713451" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638139917571713451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571703461" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638139917571713451" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_638139917571713451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571703461" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_638139917571713451" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638139917571713451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571703461" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638139917571713451" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_638139917571713451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571703461" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_638139917571713451" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6381399175717134511"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638139917571703461" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6381399175717134511" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended" xlink:title="40905 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638139917571713451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638139917571713451" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_638139917571713451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638139917571713451" xlink:to="us-gaap_IncomeStatementLocationAxis_638139917571713451" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_638139917571723422"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_638139917571713451" xlink:to="us-gaap_IncomeStatementLocationDomain_638139917571723422" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember_638139917571723422"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638139917571723422" xlink:to="us-gaap_CostOfSalesMember_638139917571723422" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_638139917571723422"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638139917571723422" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_638139917571723422" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_638139917571723422"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638139917571723422" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_638139917571723422" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638139917571723422"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638139917571713451" xlink:to="us-gaap_AwardTypeAxis_638139917571723422" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571723422"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638139917571723422" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571723422" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember_638139917571723422"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638139917571723422" xlink:to="us-gaap_PerformanceSharesMember_638139917571723422" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638139917571723422"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638139917571713451" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638139917571723422" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_638139917571723422"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638139917571723422" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_638139917571723422" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_638139917571723422"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638139917571723422" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_638139917571723422" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureBasicAndDilutedLossPerShareDetails" xlink:type="extended" xlink:title="41001 - Disclosure - BASIC AND DILUTED LOSS PER SHARE (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract_1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="us-gaap_EarningsPerShareBasicAbstract_638139917571733586"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_1" xlink:to="us-gaap_EarningsPerShareBasicAbstract_638139917571733586" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_638139917571733586"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract_638139917571733586" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_638139917571733586" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638139917571733586"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract_638139917571733586" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638139917571733586" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638139917571733586"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract_638139917571733586" xlink:to="us-gaap_EarningsPerShareBasic_638139917571733586" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="us-gaap_EarningsPerShareDilutedAbstract_638139917571733586"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_1" xlink:to="us-gaap_EarningsPerShareDilutedAbstract_638139917571733586" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_638139917571733586"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedAbstract_638139917571733586" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_638139917571733586" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638139917571733586"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedAbstract_638139917571733586" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638139917571733586" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638139917571733586"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedAbstract_638139917571733586" xlink:to="us-gaap_EarningsPerShareDiluted_638139917571733586" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureBasicAndDilutedLossPerShareAntidilutiveSecuritiesDetails" xlink:type="extended" xlink:title="41002 - Disclosure - BASIC AND DILUTED LOSS PER SHARE - Antidilutive Securities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract_3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638139917571743521"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_3" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638139917571743521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_638139917571743521"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638139917571743521" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_638139917571743521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_638139917571743521"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_638139917571743521" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_638139917571743521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638139917571743521"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_638139917571743521" xlink:to="us-gaap_EmployeeStockOptionMember_638139917571743521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_638139917571743521"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_638139917571743521" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_638139917571743521" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember_638139917571743521"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_638139917571743521" xlink:to="us-gaap_WarrantMember_638139917571743521" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638139917571743521"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638139917571743521" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638139917571743521" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_638139917571743521"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638139917571743521" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_638139917571743521" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIncomeTaxesComponentsOfNetLossForIncomeTaxDetails" xlink:type="extended" xlink:title="41101 - Disclosure - INCOME TAXES - Components of Net Loss for Income Tax (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_638139917571753453"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_638139917571753453" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_638139917571753453"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_638139917571753453" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638139917571753453"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638139917571753453" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxProvisionComputedAtStatutoryRatesDetails" xlink:type="extended" xlink:title="41102 - Disclosure - INCOME TAXES - Reconciliation of Income Tax Provision Computed at Statutory Rates (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_638139917571753453"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_638139917571753453" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_IncomeTaxReconciliationChangeInDerivativeLiability" xlink:label="hsdt_IncomeTaxReconciliationChangeInDerivativeLiability_638139917571753453"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453" xlink:to="hsdt_IncomeTaxReconciliationChangeInDerivativeLiability_638139917571753453" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_638139917571753453"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_638139917571753453" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_638139917571753453"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_638139917571753453" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_638139917571753453"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits_638139917571753453" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_638139917571753453"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_638139917571753453" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_638139917571763431"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_638139917571763431" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_638139917571763431"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_638139917571763431" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_638139917571763431"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_638139917571763431" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638139917571763431"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_638139917571753453" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638139917571763431" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIncomeTaxesComponentsOfDeferredIncomeTaxAssetsAndLiabilitiesDetails" xlink:type="extended" xlink:title="41103 - Disclosure - INCOME TAXES - Components of Deferred Income Tax Assets and Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638139917571763431"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638139917571763431" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_638139917571763431"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_638139917571763431" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_638139917571763431"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_638139917571763431" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_638139917571763431"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_638139917571763431" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_638139917571773450"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_638139917571773450" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_638139917571773450"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" xlink:to="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_638139917571773450" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_638139917571773450"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_638139917571773450" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_DeferredTaxAssetsLeaseLiability" xlink:label="hsdt_DeferredTaxAssetsLeaseLiability_638139917571773450"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" xlink:to="hsdt_DeferredTaxAssetsLeaseLiability_638139917571773450" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory_638139917571773450"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" xlink:to="us-gaap_DeferredTaxAssetsInventory_638139917571773450" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross_638139917571773450"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638139917571763431" xlink:to="us-gaap_DeferredTaxAssetsGross_638139917571773450" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_638139917571773450"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_638139917571773450" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_638139917571773450"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_638139917571773450" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_638139917571773450" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_638139917571773450"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_638139917571773450" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_638139917571773450" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="hsdt_DeferredTaxLiabilitiesRightOfUseAssets_638139917571773450"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_638139917571773450" xlink:to="hsdt_DeferredTaxLiabilitiesRightOfUseAssets_638139917571773450" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains" xlink:label="us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_638139917571783602"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_638139917571773450" xlink:to="us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains_638139917571783602" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_638139917571783602"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_638139917571773450" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_638139917571783602" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_638139917571783602"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_638139917571783602" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_638139917571783602"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_638139917571783602" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIncomeTaxesNetOperatingLossesDetails" xlink:type="extended" xlink:title="41104 - Disclosure - INCOME TAXES - Net operating losses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_IncomeTaxesTable" xlink:label="hsdt_IncomeTaxesTable_638139917571783602"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="hsdt_IncomeTaxesTable_638139917571783602" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ExpirationPeriodAxis" xlink:label="hsdt_ExpirationPeriodAxis_638139917571783602"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesTable_638139917571783602" xlink:to="hsdt_ExpirationPeriodAxis_638139917571783602" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ExpirationPeriodDomain" xlink:label="hsdt_ExpirationPeriodDomain_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ExpirationPeriodAxis_638139917571783602" xlink:to="hsdt_ExpirationPeriodDomain_638139917571793461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_OperatingLossCarryforwardExpirationPeriod1Member" xlink:label="hsdt_OperatingLossCarryforwardExpirationPeriod1Member_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ExpirationPeriodDomain_638139917571793461" xlink:to="hsdt_OperatingLossCarryforwardExpirationPeriod1Member_638139917571793461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_OperatingLossCarryforwardExpirationPeriod2Member" xlink:label="hsdt_OperatingLossCarryforwardExpirationPeriod2Member_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ExpirationPeriodDomain_638139917571793461" xlink:to="hsdt_OperatingLossCarryforwardExpirationPeriod2Member_638139917571793461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_IndefiniteOneMember" xlink:label="hsdt_IndefiniteOneMember_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ExpirationPeriodDomain_638139917571793461" xlink:to="hsdt_IndefiniteOneMember_638139917571793461" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesTable_638139917571783602" xlink:to="us-gaap_IncomeTaxAuthorityAxis_638139917571793461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis_638139917571793461" xlink:to="us-gaap_IncomeTaxAuthorityDomain_638139917571793461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain_638139917571793461" xlink:to="us-gaap_DomesticCountryMember_638139917571793461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain_638139917571793461" xlink:to="us-gaap_ForeignCountryMember_638139917571793461" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain_638139917571793461" xlink:to="us-gaap_StateAndLocalJurisdictionMember_638139917571793461" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesTable_638139917571783602" xlink:to="srt_RangeAxis_638139917571793461" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638139917571793461" xlink:to="srt_RangeMember_638139917571793461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638139917571793461"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638139917571793461" xlink:to="srt_MinimumMember_638139917571793461" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638139917571803451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638139917571793461" xlink:to="srt_MaximumMember_638139917571803451" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_IncomeTaxesLineItems" xlink:label="hsdt_IncomeTaxesLineItems_638139917571803451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesTable_638139917571783602" xlink:to="hsdt_IncomeTaxesLineItems_638139917571803451" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards_638139917571803451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesLineItems_638139917571803451" xlink:to="us-gaap_OperatingLossCarryforwards_638139917571803451" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate_638139917571803451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesLineItems_638139917571803451" xlink:to="us-gaap_OperatingLossCarryforwardsExpirationDate_638139917571803451" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsCurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsCurrent_638139917571803451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesLineItems_638139917571803451" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsCurrent_638139917571803451" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureIncomeTaxesTaxCreditCarryforwardDetails" xlink:type="extended" xlink:title="41105 - Disclosure - INCOME TAXES - Tax credit carryforward (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract_1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_IncomeTaxesTable" xlink:label="hsdt_IncomeTaxesTable_638139917571803451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract_1" xlink:to="hsdt_IncomeTaxesTable_638139917571803451" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis_638139917571803451"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesTable_638139917571803451" xlink:to="us-gaap_TaxCreditCarryforwardAxis_638139917571803451" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis_638139917571803451" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_638139917571813523" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain_638139917571813523" xlink:to="us-gaap_ResearchMember_638139917571813523" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesTable_638139917571803451" xlink:to="us-gaap_IncomeTaxAuthorityAxis_638139917571813523" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis_638139917571813523" xlink:to="us-gaap_IncomeTaxAuthorityDomain_638139917571813523" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain_638139917571813523" xlink:to="us-gaap_DomesticCountryMember_638139917571813523" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain_638139917571813523" xlink:to="us-gaap_ForeignCountryMember_638139917571813523" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ExpirationPeriodAxis" xlink:label="hsdt_ExpirationPeriodAxis_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesTable_638139917571803451" xlink:to="hsdt_ExpirationPeriodAxis_638139917571813523" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_ExpirationPeriodDomain" xlink:label="hsdt_ExpirationPeriodDomain_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ExpirationPeriodAxis_638139917571813523" xlink:to="hsdt_ExpirationPeriodDomain_638139917571813523" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_TaxCreditCarryforwardExpirationPeriod1Member" xlink:label="hsdt_TaxCreditCarryforwardExpirationPeriod1Member_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ExpirationPeriodDomain_638139917571813523" xlink:to="hsdt_TaxCreditCarryforwardExpirationPeriod1Member_638139917571813523" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_TaxCreditCarryforwardExpirationPeriod2Member" xlink:label="hsdt_TaxCreditCarryforwardExpirationPeriod2Member_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_ExpirationPeriodDomain_638139917571813523" xlink:to="hsdt_TaxCreditCarryforwardExpirationPeriod2Member_638139917571813523" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesTable_638139917571803451" xlink:to="srt_RangeAxis_638139917571813523" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638139917571813523"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638139917571813523" xlink:to="srt_RangeMember_638139917571813523" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638139917571823458"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638139917571813523" xlink:to="srt_MinimumMember_638139917571823458" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638139917571823458"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638139917571813523" xlink:to="srt_MaximumMember_638139917571823458" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_IncomeTaxesLineItems" xlink:label="hsdt_IncomeTaxesLineItems_638139917571823458"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesTable_638139917571803451" xlink:to="hsdt_IncomeTaxesLineItems_638139917571823458" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount_638139917571823458"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesLineItems_638139917571823458" xlink:to="us-gaap_TaxCreditCarryforwardAmount_638139917571823458" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardExpirationDate" xlink:label="us-gaap_TaxCreditCarryforwardExpirationDate_638139917571823458"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_IncomeTaxesLineItems_638139917571823458" xlink:to="us-gaap_TaxCreditCarryforwardExpirationDate_638139917571823458" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureDefinedContributionPlanDetails" xlink:type="extended" xlink:title="41201 - Disclosure - DEFINED CONTRIBUTION PLAN (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanAbstract" xlink:label="us-gaap_DefinedContributionPlanAbstract_1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_DefinedContributionPlanFirstEmployerMatchingContributionPercentOfEmployeesGrossPay" xlink:label="hsdt_DefinedContributionPlanFirstEmployerMatchingContributionPercentOfEmployeesGrossPay_638139917571823458"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanAbstract_1" xlink:to="hsdt_DefinedContributionPlanFirstEmployerMatchingContributionPercentOfEmployeesGrossPay_638139917571823458" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_DefinedContributionPlanNextEmployerMatchingContributionPercentOfEmployeesGrossPay" xlink:label="hsdt_DefinedContributionPlanNextEmployerMatchingContributionPercentOfEmployeesGrossPay_638139917571823458"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanAbstract_1" xlink:to="hsdt_DefinedContributionPlanNextEmployerMatchingContributionPercentOfEmployeesGrossPay_638139917571823458" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_638139917571833449"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanAbstract_1" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_638139917571833449" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:label="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_638139917571833449"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanAbstract_1" xlink:to="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_638139917571833449" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_638139917571833449"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanAbstract_1" xlink:to="us-gaap_DefinedContributionPlanCostRecognized_638139917571833449" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/20220331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="extended" xlink:title="41301 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_CommitmentsAndContingenciesTable" xlink:label="hsdt_CommitmentsAndContingenciesTable_638139917571833449"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="hsdt_CommitmentsAndContingenciesTable_638139917571833449" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_638139917571833449"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_CommitmentsAndContingenciesTable_638139917571833449" xlink:to="srt_CounterpartyNameAxis_638139917571833449" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_638139917571833449"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_638139917571833449" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_638139917571833449" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_AdvancedNeuroRehabilitationLimitedLiabilityCompanyMember" xlink:label="hsdt_AdvancedNeuroRehabilitationLimitedLiabilityCompanyMember_638139917571833449"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638139917571833449" xlink:to="hsdt_AdvancedNeuroRehabilitationLimitedLiabilityCompanyMember_638139917571833449" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638139917571833449"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_CommitmentsAndContingenciesTable_638139917571833449" xlink:to="us-gaap_TypeOfArrangementAxis_638139917571833449" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638139917571833449"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638139917571833449" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638139917571833449" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_LicenseAgreementForExclusiveRightsOnPatentPendingTechnologyMember" xlink:label="hsdt_LicenseAgreementForExclusiveRightsOnPatentPendingTechnologyMember_638139917571843459"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638139917571833449" xlink:to="hsdt_LicenseAgreementForExclusiveRightsOnPatentPendingTechnologyMember_638139917571843459" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_CommitmentsAndContingenciesLineItems" xlink:label="hsdt_CommitmentsAndContingenciesLineItems_638139917571843459"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_CommitmentsAndContingenciesTable_638139917571833449" xlink:to="hsdt_CommitmentsAndContingenciesLineItems_638139917571843459" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_PercentageOfRoyaltyOnNetRevenue" xlink:label="hsdt_PercentageOfRoyaltyOnNetRevenue_638139917571843459"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_CommitmentsAndContingenciesLineItems_638139917571843459" xlink:to="hsdt_PercentageOfRoyaltyOnNetRevenue_638139917571843459" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense_638139917571843459"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hsdt_CommitmentsAndContingenciesLineItems_638139917571843459" xlink:to="us-gaap_RoyaltyExpense_638139917571843459" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"/>
</presentationLink>
<presentationLink xlink:role="http://www.heliusmedical.com/role/DisclosureEnterpriseWideDisclosuresDetails" xlink:type="extended" xlink:title="41401 - Disclosure - ENTERPRISE-WIDE DISCLOSURES (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract_2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable_638139917571903242"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract_2" xlink:to="us-gaap_DisaggregationOfRevenueTable_638139917571903242" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_638139917571903242"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable_638139917571903242" xlink:to="srt_StatementGeographicalAxis_638139917571903242" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_638139917571903242"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis_638139917571903242" xlink:to="srt_SegmentGeographicalDomain_638139917571903242" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US_638139917571903242"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638139917571903242" xlink:to="country_US_638139917571903242" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA" xlink:label="country_CA_638139917571903242"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638139917571903242" xlink:to="country_CA_638139917571903242" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_638139917571903242"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable_638139917571903242" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_638139917571903242" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_638139917571903242"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis_638139917571903242" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_638139917571903242" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_638139917571903242"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain_638139917571903242" xlink:to="us-gaap_RevenueFromContractWithCustomerMember_638139917571903242" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember_638139917571913237"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain_638139917571903242" xlink:to="us-gaap_AccountsReceivableMember_638139917571913237" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_638139917571913237"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable_638139917571903242" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_638139917571913237" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_638139917571913237"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis_638139917571913237" xlink:to="us-gaap_ConcentrationRiskTypeDomain_638139917571913237" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember_638139917571913237"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain_638139917571913237" xlink:to="us-gaap_CustomerConcentrationRiskMember_638139917571913237" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis_638139917571913237"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable_638139917571903242" xlink:to="srt_MajorCustomersAxis_638139917571913237" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_638139917571913237"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis_638139917571913237" xlink:to="srt_NameOfMajorCustomerDomain_638139917571913237" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_CustomerOneMember" xlink:label="hsdt_CustomerOneMember_638139917571913237"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain_638139917571913237" xlink:to="hsdt_CustomerOneMember_638139917571913237" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="hsdt-20221231.xsd#hsdt_CustomerTwoMember" xlink:label="hsdt_CustomerTwoMember_638139917571913237"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain_638139917571913237" xlink:to="hsdt_CustomerTwoMember_638139917571913237" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_638139917571913237"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable_638139917571903242" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_638139917571913237" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638139917571923509"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems_638139917571913237" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638139917571923509" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueNotFromContractWithCustomerOther" xlink:label="us-gaap_RevenueNotFromContractWithCustomerOther_638139917571923509"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems_638139917571913237" xlink:to="us-gaap_RevenueNotFromContractWithCustomerOther_638139917571923509" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_638139917571923509"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems_638139917571913237" xlink:to="us-gaap_Revenues_638139917571923509" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1_638139917571923509"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems_638139917571913237" xlink:to="us-gaap_ConcentrationRiskPercentage1_638139917571923509" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"/>
</presentationLink>
</link:linkbase>

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/23/23  Helius Medical Technologies, Inc. 424B5                  1:387K                                   Toppan Merrill/FA
 5/25/23  Helius Medical Technologies, Inc. S-3/A                  3:378K                                   Toppan Merrill/FA
 3/10/23  Helius Medical Technologies, Inc. S-3                    9:1.1M                                   Toppan Merrill/FA

27 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/30/22  Helius Medical Technologies, Inc. 8-K:4,9     9/26/22   11:182K                                   Toppan Merrill Bridge/FA
 8/09/22  Helius Medical Technologies, Inc. 8-K:1,3,8,9 8/05/22   16:1M                                     Toppan Merrill/FA
 2/18/22  Helius Medical Technologies, Inc. 8-K:5,9     2/16/22   12:618K                                   ActiveDisclosure/FA
 9/03/21  Helius Medical Technologies, Inc. S-1                    5:483K                                   Donnelley … Solutions/FA
 9/02/21  Helius Medical Technologies, Inc. 8-K:1,3,9   9/01/21   12:556K                                   Donnelley … Solutions/FA
 7/07/21  Helius Medical Technologies, Inc. S-8         7/07/21    5:268K                                   Donnelley … Solutions/FA
 6/15/21  Helius Medical Technologies, Inc. 8-K:5,7,9   6/14/21    5:638K                                   ActiveDisclosure/FA
 5/27/21  Helius Medical Technologies, Inc. 8-K:5,9     5/25/21    2:97K                                    ActiveDisclosure/FA
 5/17/21  Helius Medical Technologies, Inc. 10-Q        3/31/21   57:7.5M                                   ActiveDisclosure/FA
 4/07/21  Helius Medical Technologies, Inc. 8-K:5,9     4/01/21    3:159K                                   ActiveDisclosure/FA
 3/10/21  Helius Medical Technologies, Inc. 10-K       12/31/20   75:11M                                    ActiveDisclosure/FA
 2/01/21  Helius Medical Technologies, Inc. 8-K:1,3,8,9 1/28/21    5:522K                                   ActiveDisclosure/FA
 1/20/21  Helius Medical Technologies, Inc. S-1/A                 81:14M                                    Donnelley … Solutions/FA
12/31/20  Helius Medical Technologies, Inc. 8-K:3,5,8,912/31/20    3:73K                                    ActiveDisclosure/FA
10/26/20  Helius Medical Technologies, Inc. 8-K:1,3,8,910/21/20    4:504K                                   ActiveDisclosure/FA
10/07/20  Helius Medical Technologies, Inc. 8-K:5,9    10/05/20    2:193K                                   ActiveDisclosure/FA
 3/14/19  Helius Medical Technologies, Inc. 10-K       12/31/18   74:13M                                    ActiveDisclosure/FA
11/08/18  Helius Medical Technologies, Inc. 10-Q        9/30/18   64:11M                                    ActiveDisclosure/FA
10/30/18  Helius Medical Technologies, Inc. 8-K:5,9    10/24/18    2:50K                                    Donnelley … Solutions/FA
 8/09/18  Helius Medical Technologies, Inc. 10-Q        6/30/18   65:11M                                    ActiveDisclosure/FA
11/09/17  Helius Medical Technologies, Inc. 10-Q        9/30/17   57:7.5M                                   ActiveDisclosure/FA
11/02/17  Helius Medical Technologies, Inc. 8-K:1,9    10/30/17    2:63K                                    ActiveDisclosure/FA
 5/18/17  Helius Medical Technologies, Inc. S-8         5/18/17    9:1.2M                                   Donnelley … Solutions/FA
 4/03/17  Helius Medical Technologies, Inc. 10-KT      12/31/16   71:10M                                    ActiveDisclosure/FA
10/16/15  Helius Medical Technologies, Inc. 8-K:1,2,3,810/09/15    4:199K                                   Newsfile Corp./FA
 9/23/14  Helius Medical Technologies, Inc. S-1/A                 11:1.3M                                   Newsfile Corp./FA
 7/14/14  Helius Medical Technologies, Inc. S-1         7/11/14   16:7.9M                                   Michener Lang
↑Top
Filing Submission 0001558370-23-003338   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 5:49:28.2am ET